Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991800

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991686

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991818

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991584

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294991585

Question 3

10/16/2019

Safe and comprehensive treatment of opioid use disorder with buprenorphine in the outpatient setting in close collaboration with nurses is possible because many aspects of care can be based on established protocols.   True true Evidence supports collaboration with nurses and other collaborative t

/Templates/Article.aspx?id=4294991488

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991486

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294991487

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294991938

Choosing Wisely Diabetes Management Exam

10/16/2019

EXAM Choosing Wisely - Diabetes Management in an Aging Population 70 true Please answer the following questions. A score of at least 70% is required to receive AMA PRA Category 1 Credits.™   4294983966 true true 4294983967 true true 4294983968 true true

/Templates/CME/Exam.aspx?id=4294983971